SPINOCEREBELLAR ATAXIA 3 (SCA3) DNA DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited    |
The SCA3 DNA Detection test identifies abnormal CAG repeat expansions in the ATXN3 gene responsible for Spinocerebellar Ataxia Type 3, also known as Machado–Joseph disease. This inherited neurological disorder leads to progressive balance issues, muscle stiffness, coordination problems, and difficulty with eye movements. Using EDTA blood, Metropolis Healthcare performs precise molecular analysis to confirm the genetic mutation. Early diagnosis helps guide treatment decisions, prognosis, and genetic counseling for affected families
 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,275.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0004

Frequently Asked Questions (FAQ's):

What does the SCA3 DNA detection test check for?
It detects CAG repeat expansions in the ATXN3 gene that cause Spinocerebellar Ataxia Type 3.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular techniques to measure repeat length accurately from EDTA blood.

Who should undergo this test?
Individuals with symptoms of ataxia or those with a family history of SCA3.

What sample is required for the test?
EDTA blood is needed for DNA extraction and genetic analysis.

Does this test provide a confirmed diagnosis?
Yes, identifying an expanded CAG repeat confirms the presence of SCA3.

Is any preparation needed before giving the sample?
No fasting or special preparation is required.

How can the results help the patient?
Results assist in diagnosis, planning supportive care, and genetic counseling.

Can family members also be tested at Metropolis Healthcare?
Yes, once a mutation is identified, relatives can undergo targeted or predictive testing at Metropolis Healthcare

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab